We are live on ! Find out more
BDF

Balasa Dinverno & Foltz Portfolio holdings

AUM $1.58B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
+4%
1 Year Est. Return
-17.55%
3 Year Est. Return
+23.2%
5 Year Est. Return
+47.16%
10 Year Est. Return
AUM
$690M
AUM Growth
+$30.2M
Cap. Flow
+$4.69M
Cap. Flow %
0.68%
Top 10 Hldgs %
73.54%
Holding
235
New
25
Increased
97
Reduced
81
Closed
9

Top Buys

Rank Stock Value
1
WTV icon
WisdomTree US Value Fund
WTV
+$2.17M
2
EL icon
Estee Lauder
EL
+$1.38M
3
MU icon
Micron Technology
MU
+$891K
4
PRU icon
Prudential Financial
PRU
+$670K
5
T icon
AT&T
T
+$570K

Sector Composition

Rank Sector Weight
1 Technology 6.01%
2 Healthcare 3.83%
3 Financials 2.82%
4 Communication Services 2.16%
5 Consumer Discretionary 1.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDY icon
151
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$316K 0.05%
3,410
AVT icon
152
Avnet
AVT
$7.97B
$312K 0.05%
7,271
+1,205
+20% +$48.8K
KDP icon
153
Keurig Dr Pepper
KDP
$39.9B
$306K 0.04%
2,511
+326
+15% +$39.1K
RZV icon
154
Invesco S&P SmallCap 600 Pure Value ETF
RZV
$304M
$306K 0.04%
3,957
RTX icon
155
RTX Corp
RTX
$303B
$301K 0.04%
3,822
+86
+2% +$6.73K
PNC icon
156
PNC Financial Services
PNC
$100B
$300K 0.04%
2,222
+381
+21% +$55.6K
IJR icon
157
iShares Core S&P Small-Cap ETF
IJR
$112B
$293K 0.04%
3,514
-120
-3% -$9.78K
MDT icon
158
Medtronic
MDT
$114B
$292K 0.04%
3,410
+463
+16% +$38.7K
RZG icon
159
Invesco S&P SmallCap 600 Pure Growth ETF
RZG
$138M
$289K 0.04%
6,816
-123
-2% -$4.99K
CELG
160
DELISTED
Celgene Corp
CELG
$289K 0.04%
3,633
+241
+7% +$20K
CI icon
161
Cigna
CI
$73.7B
$287K 0.04%
1,686
-67
-4% -$11.6K
ATVI
162
DELISTED
Activision Blizzard
ATVI
$287K 0.04%
3,758
+502
+15% +$35.5K
CC
163
DELISTED
CIRCUIT CITY STORES, INC.
CC
$286K 0.04%
6,448
ANET icon
164
Arista Networks
ANET
$242B
$285K 0.04%
17,712
+112
+0.6% +$1.83K
COF icon
165
Capital One
COF
$133B
$277K 0.04%
3,016
+225
+8% +$21.3K
GSK icon
166
GSK
GSK
$104B
$277K 0.04%
5,489
EFV icon
167
iShares MSCI EAFE Value ETF
EFV
$30B
$275K 0.04%
5,365
+27
+0.5% +$1.47K
DUK icon
168
Duke Energy
DUK
$95.3B
$269K 0.04%
3,405
-1,829
-35% -$141K
RMTI icon
169
Rockwell Medical
RMTI
$27.6M
$268K 0.04%
494
LLY icon
170
Eli Lilly
LLY
$1.08T
$267K 0.04%
3,130
+65
+2% +$5.34K
SAM icon
171
Boston Beer
SAM
$1.87B
$264K 0.04%
+882
New +$215K
AIZ icon
172
Assurant
AIZ
$14.2B
$262K 0.04%
2,534
-125
-5% -$11.8K
XLV icon
173
State Street Health Care Select Sector SPDR ETF
XLV
$43.9B
$261K 0.04%
3,127
+127
+4% +$10.5K
MED icon
174
Medifast
MED
$135M
$260K 0.04%
+1,626
New +$208K
LSXMA
175
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$259K 0.04%
+7,968
New +$252K

Similar funds

Balasa Dinverno & Foltz's Q2 2018 Portfolio in Review

As of Q2 2018, Balasa Dinverno & Foltz held 235 positions worth $690M, up 4.6% from $660M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Balasa Dinverno & Foltz's Q2 2018 filing shows 25 new, 97 increased, 81 reduced and 9 closed positions. Its largest new stake was WisdomTree US Value Fund: 52,906 shares worth $2.18M. The largest sale was iShares Russell 1000 Growth ETF, an estimated $3.16M.

By sector, the portfolio is most concentrated in Technology at 6% of assets, up from 5.9% a quarter earlier, followed by Healthcare and Financials.

  • Balasa Dinverno & Foltz's largest Q2 2018 buy was WisdomTree US Value Fund: 52,906 shares worth $2.18M.
  • Balasa Dinverno & Foltz added most to Micron Technology in Q2 2018, an estimated $891K increase.
  • Balasa Dinverno & Foltz's biggest Q2 2018 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $3.16M.
  • Balasa Dinverno & Foltz fully exited Time Warner Inc in Q2 2018, selling an estimated $541K.
  • Balasa Dinverno & Foltz's ten largest holdings make up 74% of its $690M portfolio in Q2 2018.
  • Balasa Dinverno & Foltz opened 25 new positions and closed 9 in Q2 2018.
  • Balasa Dinverno & Foltz's portfolio value rose 4.6% quarter-over-quarter to $690M.

Based on Balasa Dinverno & Foltz's 13F filing for Q2 2018, filed 1 Aug 2018.